Genetic polymorphisms of CYP2C19 and effect of CYP2C19☆2 allele on clopidogrel P2Y12 inhibition in healthy Malaysian volunteers

被引:0
|
作者
Sani, Y. N. [1 ]
Lim, S. C. [1 ]
Lim, L. H. [1 ]
Edwin, N. E. Y. [1 ]
Khan, N. Abdul Karim [1 ]
Goh, T. H. [2 ]
Serebruany, V. L. [3 ]
Yuen, K. H. [1 ]
机构
[1] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia
[2] Loh Guan Lye Specialists Ctr, George Town, Malaysia
[3] Johns Hopkins Univ, Towson, MD USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:874 / 874
页数:1
相关论文
共 50 条
  • [21] The CYP2C19*2 and CYP2C19*17 Polymorphisms Influence Responses to Clozapine for the Treatment of Schizophrenia
    Rodrigues-Silva, Christielly
    Semedo, Agostinho Tavares
    da Silva Neri, Hiasmin Franciely
    Vianello, Rosana Pereira
    Galaviz-Hernandez, Carlos
    Sosa-Macias, Martha
    de Brito, Rodrigo Bernini
    Ghedini, Paulo Cesar
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2020, 16 : 427 - 432
  • [22] CYP2C19*2 and CYP2C19*3 allelomorphism in Turkish population
    Dogan, Ali
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 239 : 12 - 12
  • [23] Distribution of CYP2C19☆2 and CYP2C19☆3 polymorphisms in Venezuelan populations with different admixture
    Castro de Guerra, Dinorah
    Flores, Sara
    Helen Izaguirre, Mary
    ANNALS OF HUMAN BIOLOGY, 2013, 40 (02) : 197 - 200
  • [24] Inhibitory effect of oral contraceptives on CYP2C19 activity is not significant in carriers of the CYP2C19*17 allele
    Pedersen, Rasmus S.
    Noehr-Jensen, Lene
    Brosen, Kim
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2013, 40 (10): : 683 - 688
  • [25] The effect of CYP2C19 and CYP2C9 polymorphism on the pharmacodynamics of clopidogrel
    Jiang, Juanjuan
    Tian, Lei
    Han, Lulu
    Yan, Yan
    Huang, Yiling
    Liu, Hong
    Xie, Shuang
    Li, Yishi
    CARDIOLOGY, 2011, 120 : 30 - 31
  • [26] Rapid CYP2C19 Genotype Testing: Comparison between Spartan RX CYP2C19 and Verigene CYP2C19
    Zhou, Y.
    Armstead, A. R.
    Coshatt, G. M.
    Brott, B. C.
    Sankaranarayanan, A.
    Limdi, N. A.
    Harada, S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 845 - 845
  • [27] Clopidogrel, CYP2C19, and a Black Box
    Ford, Neville F.
    Taubert, Dirk
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (03): : 241 - 248
  • [28] Does CYP2C19 inhibition lead to clopidogrel thrombogenicity?
    Cohen, M. J.
    MEDICAL HYPOTHESES, 2011, 77 (03) : 448 - 450
  • [29] Prevalence and types of genetic polymorphisms of CYP2C19 and their effects on platelet aggregation inhibition by clopidogrel
    Aga, Q. A. A.
    Hasan, M. K.
    Nassir, K. F.
    Aga, L. A. A.
    Al-Jaidi, B. A.
    Aldhoun, M.
    Morsy, M. A.
    Nair, A. B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (21) : 11286 - 11294
  • [30] Functional characterization of two novel CYP2C19 variants (CYP2C19*18 and CYP2C19*19) found in a Japanese population
    Hanioka, N.
    Tsuneto, Y.
    Saito, Y.
    Sumada, T.
    Maekawa, K.
    Saito, K.
    Sawada, J.
    Narimatsu, S.
    XENOBIOTICA, 2007, 37 (04) : 342 - 355